Developer docs
API playgroundTry for free, no card

Search company profiles

Copner Biotech

Full company profile

uuid0027iff

Namestring
Copner Biotech
Legal namestring
Copner Biotech Ltd.
Company typeenum
Private
Founded yearint
2020
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersEbbw Vale, United Kingdom
HQ citystring
Ebbw Vale
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
3D cell culture, bioprinting technology, tissue engineering, cell culture scaffolds, biofabrication equipment
Industry1 code
PRIMARYIMAAAAAG
Bioprinting & Biofabrication Systems (Tissue/Cell Printing Hardware)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Hardware (Printers & Systems)
NAICS code1 code
  • Plastics Material and Resin Manufacturing325211
SIC code2 codes
  • Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)2820
  • Services-Commercial Physical & Biological Research8731
Product category
Biofabrication Equipment
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
13D Cell Culture Scaffolds Sales
TypeHardware Sales
Description

Sale of 3D PETG Cell Culture Scaffolds with oxygen and nutrient gradients. Available off-the-shelf through distributors or as bespoke designs. Scaffolds provide heterogenous porosity for cell infiltration and growth.

copnerbiotech.com
2Bioprinter Sales (GRAPE S1, GRAPE S1 4D)
TypeHardware Sales
Description

Sale of 3D and 4D Extrusion Bioprinters. GRAPE S1 is the entry bioprinter; GRAPE S1 4D is the flagship model with microfluidic deposition, multi-temperature zones, and cleanroom environment.

copnerbiotech.com
3GRAPE M1 Software
TypeOne Time License
Description

Bundled with GRAPE bioprinter purchase or available as standalone product through official distributors. Outputs 3D models in GRAPE and STL formats.

copnerbiotech.com
4Bespoke 3D Scaffold Design Services
TypeProfessional Services
Description

Team of modellers available to assist in creating bespoke 3D Cell Culture Scaffolds to exacting requirements. Uses bespoke Bio Scaffold modelling software.

copnerbiotech.com
5Technology Licensing
TypeLicensing Royalties
Description

Patented technology available for licence on mutually agreeable terms, with necessary technical support to help businesses make full use of those rights. Includes Bio-scaffold, additive manufacturing, GRAPE data format, heating/cooling control, assisted bioprinting, and component mixing patents.

copnerbiotech.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1GRAPE
Description

Proprietary 3D modelling data format - Graphical Rectangular Actual Positional Encoding - specifically developed for biofabrication. Registered trademark in UK, EU, and USA.

copnerbiotech.com
+1 more record
Core offering1 text field

Copner Biotech develops, manufactures and sells 3D PETG cell culture scaffolds and proprietary GRAPE S1/GRAPE S1 4D extrusion bioprinters for academic and biotechnology research. The company also offers bespoke 3D scaffold modelling services and licenses its patented GRAPE biofabrication technology on mutually agreeable terms.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Pore sizes can range from 10 to 1000 microns with interconnects between 50-400 microns
+2 more records
Product overview1 text field

Copner Biotech offers a unified portfolio of 3D cell culture and biofabrication products centered on proprietary GRAPE technology. The product line comprises: GRAPE S1 (entry-level 3D extrusion bioprinter) and GRAPE S1 4D (flagship 4D extrusion bioprinter with microfluidic technology and multi-zone temperature control); 3D PETG Cell Culture Scaffolds with heterogenous porosity for cell microenvironment research; and GRAPE M1 3D modelling software that outputs in the proprietary GRAPE format as well as STL for third-party printer compatibility. The GRAPE 3D modelling data format underpins the entire product ecosystem, enabling precise, batch-consistent biofabrication.

Product and service5 records
13D PETG Cell Culture Scaffolds
Category3D Cell Culture Consumables
Description

3D cell culture scaffolds based on concentric shape constructs providing heterogenous pore size distribution (10–1000 microns) with oxygen and nutrient gradients to maximise cell growth in physiologically relevant in vitro conditions. Available off-the-shelf through distributors or as bespoke designs for universities, research institutions, and biotech companies.

2GRAPE S1 3D Extrusion Bioprinter
Category3D Bioprinter Hardware
Description

Entry-level 3D extrusion bioprinter with high precision printing powered by GRAPE control software, bundled with GRAPE 3D modelling software and a remote control application. Targeted at researchers beginning their biofabrication journey.

3GRAPE S1 4D Extrusion Bioprinter
Category4D Bioprinter Hardware
Description

Flagship 4D extrusion bioprinter (450mm height, 385mm width, 350mm depth) employing microfluidic droplet deposition with multi-zone temperature control and a cleanroom-type environment. Print nozzle diameters range from 0.25mm to 0.05mm with positional delta movement resolution of 0.01mm; does not require external compressors or laboratory modifications.

4GRAPE M1 3D Modelling Software
Category3D Modelling Software
Description

Next-generation 3D modelling software that outputs files in both proprietary GRAPE and STL formats, enabling precise design of complex microarchitectures for 3D cell culture and tissue engineering. Available bundled with GRAPE bioprinter purchases or as a standalone product through official distributors.

5Bespoke 3D Scaffold Design Services
CategoryDesign Services
Description

Team of in-house modellers assist customers in creating bespoke 3D cell culture scaffolds to exacting requirements using bespoke Bio Scaffold modelling software. Deliverables include printable STL models for conventional 3D printers and CBL models for Copner Biotech's proprietary bioprinters.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-01
Description

Delivery of biofabrication seminar together with GRAPE S1 3D bioprinter for researchers to develop novel pancreatic models.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-01
Description

Collaboration to develop novel in vitro models of cartilage funded by NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research). Delivery of GRAPE S1 4D bioprinter and seminar.

3Northampton University and Loughborough University
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-01
Description

Collaborative biofabrication research programme to expand state-of-the-art 4D bioprinting technology for biomedical research. Building on sarcoma research, deploying GRAPE S1 4D for dynamic in-vitro models for immune disorders, cancer, and therapeutic testing.

copnerbiotech.com
4Glasgow University
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-01
Description

Collaboration on cutting edge research into treatments for Prostate Cancer. Development of novel bioprinted prostate cancer models for drug testing with Dr Syer Choon Lim.

copnerbiotech.com
5Beijing International Science and Technology Cooperation Center / UK Department of Business and Trade
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2024-12-01
Description

CEO Jordan Copner showcased Next Generation 3D Cell Culture and 4D Bioprinting Technology at China-UK Medical Technology Promotion Conference in Beijing. Co-organized by Beijing International Science and Technology Cooperation Center, Capital Science and Technology Service Industry Association, and UK Department of Business and Trade Life Sciences and Healthcare Department.

copnerbiotech.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-01
Description

Contract to supply GRAPE S1 3D Bioprinter bundled with 3D GRAPE M1 Modelling software and 3D PETG Cell Culture Scaffolds to Professor Karen Anthony's team.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-09-01
Description

Attendance at MIB Conference on In Vitro Cell Culture Models: Moving towards animal free. CTO and CFO presented biotechnology and provided free samples of award-winning animal free 3D PETG Cell Culture Scaffolds.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-08-01
Description

Partnership with leading European distributor to expand distribution network in United Kingdom and Europe for 3D Cell Culture Scaffolds.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-07-01
Description

Partnership to introduce 3D Cell Culture technologies into Australia.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

Supply of GRAPE S1 4D Bioprinter and 3D GRAPE M1 Modelling software for cultivated meat research. Collaboration with Louis Hutchings and Aston University on cutting edge R&D.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-03-01
Description

Invited to participate in Biosculpt UK-India Conference hosted by Indian Institute of Science (IISc) Bangalore. UK's National Institute for Advanced Materials Research and Innovation.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-11-01
Description

Exclusive distribution agreement covering Benelux and Spain for 3D PETG Cell Culture Scaffolds. Signed November 2023 with CEO Jordan Copner and Economy Minister Vaughan Gething.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr Sarah E. Hooper's Microbiology & Infection Research Group using Copner Biotech's bioprinter to develop and modify in vitro chronic wound infection model.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative research on efficacy of 3D PETG cell culture scaffold technology. Validation of scaffold design with fantastic cell culture results.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Working with researchers at Cardiff University School of Biosciences to validate 3D PETG scaffolds for novel forms of microscopy research.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Aspect Biosystems
TypeDirect peer
Description

Canadian bioprinting company specializing in microfluidic 3D bioprinting technology for tissue engineering and regenerative medicine. Directly comparable to Copner's microfluidic droplet deposition approach and focus on user-derived bioinks for personalized tissue constructs.

TypeDirect peer
Description

Pioneer in 3D bioprinting of human tissues for drug discovery and therapeutic applications. Comparable to Copner in addressing limitations of 2D cell culture and animal models through bioprinted tissue constructs, though focused more on pharma drug discovery partnerships than academic research tools.

TypeDirect peer
Description

Swiss manufacturer of multi-head 3D bioprinters and bioinks for tissue engineering and regenerative medicine research. Directly competes with Copner Biotech in desktop extrusion bioprinters for academic and translational research customers across Europe and globally.

TypeEmerging player
Description

Israeli biotech developing recombinant human collagen-based bioinks for 3D bioprinting of tissues and organs. Comparable to Copner in serving the biofabrication and tissue engineering market, though focused on bioink supply rather than bioprinter hardware.

TypeBroad incumbent
Description

Global leader in bioprinting and bioconvergence, offering a full ecosystem of 3D bioprinters (BIO X, BIO X6), bioinks, and lab automation. Most comparable to Copner Biotech in terms of core bioprinter and consumables offering for academic and pharma research customers, but with vastly greater scale, funding, and product breadth.

TypeDirect peer
Description

French bioprinting company developing laser-assisted 3D bioprinting technology for tissue engineering. Comparable to Copner in serving academic research customers seeking physiologically relevant 3D tissue models, though using a different printing modality.

TypeDirect peer
Description

Spanish bioprinter manufacturer offering extrusion-based bioprinting systems for tissue engineering and regenerative medicine research. Comparable to Copner Biotech in desktop extrusion bioprinter format and academic research customer focus, with similar revenue model of hardware sales plus bioink consumables.

TypeDirect peer
Description

South Korean bioprinting company offering 3D bioprinters and bioinks for regenerative medicine and drug discovery. Comparable to Copner in providing bioprinting platforms to academic research institutions, with similar focus on personalized tissue engineering applications.

TypeBroad incumbent
Description

Major life sciences supplier with extensive 3D cell culture product portfolio including scaffolds, hydrogels, and culture systems. Comparable to Copner in addressing the 2D-to-3D cell culture shift, though as a broad incumbent with established distribution and far larger product breadth.

TypeBroad incumbent
Description

Acquired Allevi (formerly Advanced BioMatrix) to enter bioprinting, offering extrusion-based bioprinters and bioinks for academic and research use. Competes with Copner in desktop extrusion bioprinters for tissue engineering and 3D cell culture applications, with broader portfolio and established distribution.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Copner Biotech

Biofabrication Equipmentcopnerbiotech.com

Copner Biotech firmographics

Firmographics
Name
Copner Biotech
Legal name
Copner Biotech Ltd.
Website
https://copnerbiotech.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Copner Biotech industry classification

Industry
Product category
Biofabrication Equipment
NAICS
Plastics Material and Resin Manufacturing (325211)
SIC
Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) (2820), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYIMAAAAAG
Bioprinting & Biofabrication Systems (Tissue/Cell Printing Hardware)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Hardware (Printers & Systems)

Keywords

  • 3D cell culture
  • Bioprinting technology
  • Tissue engineering
  • Cell culture scaffolds
  • Biofabrication equipment

Where Copner Biotech is headquartered

Location

Headquarters

HQ city
Ebbw Vale
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Copner Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. 3D Cell Culture Scaffolds Sales: Sale of 3D PETG Cell Culture Scaffolds with oxygen and nutrient gradients. Available off-the-shelf through distributors or as bespoke designs. Scaffolds provide heterogenous porosity for cell infiltration and growth.
  2. Bioprinter Sales (GRAPE S1, GRAPE S1 4D): Sale of 3D and 4D Extrusion Bioprinters. GRAPE S1 is the entry bioprinter; GRAPE S1 4D is the flagship model with microfluidic deposition, multi-temperature zones, and cleanroom environment.
  3. GRAPE M1 Software: Bundled with GRAPE bioprinter purchase or available as standalone product through official distributors. Outputs 3D models in GRAPE and STL formats.
  4. Bespoke 3D Scaffold Design Services: Team of modellers available to assist in creating bespoke 3D Cell Culture Scaffolds to exacting requirements. Uses bespoke Bio Scaffold modelling software.
  5. Technology Licensing: Patented technology available for licence on mutually agreeable terms, with necessary technical support to help businesses make full use of those rights. Includes Bio-scaffold, additive manufacturing, GRAPE data format, heating/cooling control, assisted bioprinting, and component mixing patents.

Go-to-market motion2 records

Distribution channels7 records

Marketing channels6 records

Copner Biotech product offering

Product offering

Core offering

Copner Biotech develops, manufactures and sells 3D PETG cell culture scaffolds and proprietary GRAPE S1/GRAPE S1 4D extrusion bioprinters for academic and biotechnology research. The company also offers bespoke 3D scaffold modelling services and licenses its patented GRAPE biofabrication technology on mutually agreeable terms.

Product overview

Copner Biotech offers a unified portfolio of 3D cell culture and biofabrication products centered on proprietary GRAPE technology. The product line comprises: GRAPE S1 (entry-level 3D extrusion bioprinter) and GRAPE S1 4D (flagship 4D extrusion bioprinter with microfluidic technology and multi-zone temperature control); 3D PETG Cell Culture Scaffolds with heterogenous porosity for cell microenvironment research; and GRAPE M1 3D modelling software that outputs in the proprietary GRAPE format as well as STL for third-party printer compatibility. The GRAPE 3D modelling data format underpins the entire product ecosystem, enabling precise, batch-consistent biofabrication.

Differentiator

Problem solved

Functional benefit

Brands

  • GRAPE: Proprietary 3D modelling data format - Graphical Rectangular Actual Positional Encoding - specifically developed for biofabrication. Registered trademark in UK, EU, and USA.
  • Renderable Biofabrication

Products and services

  • 3D PETG Cell Culture Scaffolds 3D cell culture scaffolds based on concentric shape constructs providing heterogenous pore size distribution (10–1000 microns) with oxygen and nutrient gradients to maximise cell growth in physiologically relevant in vitro conditions. Available off-the-shelf through distributors or as bespoke designs for universities, research institutions, and biotech companies.
  • GRAPE S1 3D Extrusion Bioprinter Entry-level 3D extrusion bioprinter with high precision printing powered by GRAPE control software, bundled with GRAPE 3D modelling software and a remote control application. Targeted at researchers beginning their biofabrication journey.
  • GRAPE S1 4D Extrusion Bioprinter Flagship 4D extrusion bioprinter (450mm height, 385mm width, 350mm depth) employing microfluidic droplet deposition with multi-zone temperature control and a cleanroom-type environment. Print nozzle diameters range from 0.25mm to 0.05mm with positional delta movement resolution of 0.01mm; does not require external compressors or laboratory modifications.
  • GRAPE M1 3D Modelling Software Next-generation 3D modelling software that outputs files in both proprietary GRAPE and STL formats, enabling precise design of complex microarchitectures for 3D cell culture and tissue engineering. Available bundled with GRAPE bioprinter purchases or as a standalone product through official distributors.
  • Bespoke 3D Scaffold Design Services Team of in-house modellers assist customers in creating bespoke 3D cell culture scaffolds to exacting requirements using bespoke Bio Scaffold modelling software. Deliverables include printable STL models for conventional 3D printers and CBL models for Copner Biotech's proprietary bioprinters.

Quantifiable outcome

  • Pore sizes can range from 10 to 1000 microns with interconnects between 50-400 microns
  • +2 more outcomes

Companies that use Copner Biotech

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Copner Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Copner Biotech partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered core and minor.

  • University of HullcoreStrategic or Co-development Partner · 1 April 2026Delivery of biofabrication seminar together with GRAPE S1 3D bioprinter for researchers to develop novel pancreatic models.
  • Newcastle University and Northumbria UniversitycoreStrategic or Co-development Partner · 1 March 2026Collaboration to develop novel in vitro models of cartilage funded by NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research). Delivery of GRAPE S1 4D bioprinter and seminar.
  • Northampton University and Loughborough UniversitycoreStrategic or Co-development Partner · 1 November 2025Collaborative biofabrication research programme to expand state-of-the-art 4D bioprinting technology for biomedical research. Building on sarcoma research, deploying GRAPE S1 4D for dynamic in-vitro models for immune disorders, cancer, and therapeutic testing.
  • Glasgow UniversitycoreStrategic or Co-development Partner · 1 June 2025Collaboration on cutting edge research into treatments for Prostate Cancer. Development of novel bioprinted prostate cancer models for drug testing with Dr Syer Choon Lim.
  • Beijing International Science and Technology Cooperation Center / UK Department of Business and TrademinorGTM or Marketing Partner · 1 December 2024CEO Jordan Copner showcased Next Generation 3D Cell Culture and 4D Bioprinting Technology at China-UK Medical Technology Promotion Conference in Beijing. Co-organized by Beijing International Science and Technology Cooperation Center, Capital Science and Technology Service Industry Association, and UK Department of Business and Trade Life Sciences and Healthcare Department.
  • Northampton UniversitycoreStrategic or Co-development Partner · 1 November 2024Contract to supply GRAPE S1 3D Bioprinter bundled with 3D GRAPE M1 Modelling software and 3D PETG Cell Culture Scaffolds to Professor Karen Anthony's team.
  • Manchester Institute of BiotechnologyminorStrategic or Co-development Partner · 1 September 2024Attendance at MIB Conference on In Vitro Cell Culture Models: Moving towards animal free. CTO and CFO presented biotechnology and provided free samples of award-winning animal free 3D PETG Cell Culture Scaffolds.
  • CliniSciencescoreChannel Partner/ Reseller/ Distributor · 1 August 2024Partnership with leading European distributor to expand distribution network in United Kingdom and Europe for 3D Cell Culture Scaffolds.
  • Custom SciencecoreChannel Partner/ Reseller/ Distributor · 1 July 2024Partnership to introduce 3D Cell Culture technologies into Australia.
  • Aston UniversitycoreStrategic or Co-development Partner · 1 April 2024Supply of GRAPE S1 4D Bioprinter and 3D GRAPE M1 Modelling software for cultivated meat research. Collaboration with Louis Hutchings and Aston University on cutting edge R&D.
  • Henry Royce InstituteminorStrategic or Co-development Partner · 1 March 2024Invited to participate in Biosculpt UK-India Conference hosted by Indian Institute of Science (IISc) Bangalore. UK's National Institute for Advanced Materials Research and Innovation.
  • ISOGEN LifesciencecoreChannel Partner/ Reseller/ Distributor · 1 November 2023Exclusive distribution agreement covering Benelux and Spain for 3D PETG Cell Culture Scaffolds. Signed November 2023 with CEO Jordan Copner and Economy Minister Vaughan Gething.
  • Cardiff Metropolitan UniversitycoreStrategic or Co-development PartnerDr Sarah E. Hooper's Microbiology & Infection Research Group using Copner Biotech's bioprinter to develop and modify in vitro chronic wound infection model.
  • Swansea University (Accelerate Healthcare Technology Centre)coreStrategic or Co-development PartnerCollaborative research on efficacy of 3D PETG cell culture scaffold technology. Validation of scaffold design with fantastic cell culture results.
  • Cardiff UniversitycoreStrategic or Co-development PartnerWorking with researchers at Cardiff University School of Biosciences to validate 3D PETG scaffolds for novel forms of microscopy research.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Copner Biotech competitors and assessment

Company assessment

Direct peers

  • Aspect Biosystems: Canadian bioprinting company specializing in microfluidic 3D bioprinting technology for tissue engineering and regenerative medicine. Directly comparable to Copner's microfluidic droplet deposition approach and focus on user-derived bioinks for personalized tissue constructs.
  • Organovo: Pioneer in 3D bioprinting of human tissues for drug discovery and therapeutic applications. Comparable to Copner in addressing limitations of 2D cell culture and animal models through bioprinted tissue constructs, though focused more on pharma drug discovery partnerships than academic research tools.
  • RegenHU: Swiss manufacturer of multi-head 3D bioprinters and bioinks for tissue engineering and regenerative medicine research. Directly competes with Copner Biotech in desktop extrusion bioprinters for academic and translational research customers across Europe and globally.
  • Poietis: French bioprinting company developing laser-assisted 3D bioprinting technology for tissue engineering. Comparable to Copner in serving academic research customers seeking physiologically relevant 3D tissue models, though using a different printing modality.
  • Regemat 3D: Spanish bioprinter manufacturer offering extrusion-based bioprinting systems for tissue engineering and regenerative medicine research. Comparable to Copner Biotech in desktop extrusion bioprinter format and academic research customer focus, with similar revenue model of hardware sales plus bioink consumables.
  • Rokit Healthcare: South Korean bioprinting company offering 3D bioprinters and bioinks for regenerative medicine and drug discovery. Comparable to Copner in providing bioprinting platforms to academic research institutions, with similar focus on personalized tissue engineering applications.

Emerging players

  • CollPlant Biotechnologies: Israeli biotech developing recombinant human collagen-based bioinks for 3D bioprinting of tissues and organs. Comparable to Copner in serving the biofabrication and tissue engineering market, though focused on bioink supply rather than bioprinter hardware.

Broad incumbents

  • BICO (CELLINK): Global leader in bioprinting and bioconvergence, offering a full ecosystem of 3D bioprinters (BIO X, BIO X6), bioinks, and lab automation. Most comparable to Copner Biotech in terms of core bioprinter and consumables offering for academic and pharma research customers, but with vastly greater scale, funding, and product breadth.
  • Corning (Matrigel, 3D cell culture portfolio): Major life sciences supplier with extensive 3D cell culture product portfolio including scaffolds, hydrogels, and culture systems. Comparable to Copner in addressing the 2D-to-3D cell culture shift, though as a broad incumbent with established distribution and far larger product breadth.
  • 3D Systems (Allevi): Acquired Allevi (formerly Advanced BioMatrix) to enter bioprinting, offering extrusion-based bioprinters and bioinks for academic and research use. Competes with Copner in desktop extrusion bioprinters for tissue engineering and 3D cell culture applications, with broader portfolio and established distribution.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

Copner Biotech social profiles

Digital presence

Copner Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Copner Biotech leadership team

Management profile

Number of profiles

Profiles5 records

Copner Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Copner Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Copner Biotech

What does Copner Biotech do?

Copner Biotech develops, manufactures and sells 3D PETG cell culture scaffolds and proprietary GRAPE S1/GRAPE S1 4D extrusion bioprinters for academic and biotechnology research. The company also offers bespoke 3D scaffold modelling services and licenses its patented GRAPE biofabrication technology on mutually agreeable terms.

Is Copner Biotech a public or private company?

Copner Biotech is a private company. It is classified as family owned and is currently operating.

When was Copner Biotech founded?

Copner Biotech was founded in 2020. It employs 1 to 10 people.

Where is Copner Biotech based?

Copner Biotech is headquartered in Ebbw Vale, United Kingdom, in the Europe region.

How does Copner Biotech make money?

Five revenue lines are on record. 3D Cell Culture Scaffolds Sales are the primary driver. The others are bioprinter Sales (GRAPE S1, GRAPE S1 4D), GRAPE M1 Software, bespoke 3D Scaffold Design Services and technology Licensing.

Who are Copner Biotech's main competitors?

Direct peers on record are Aspect Biosystems, Organovo, RegenHU, Poietis, Regemat 3D and Rokit Healthcare. CollPlant Biotechnologies is listed as an emerging player. Broad incumbents are BICO (CELLINK), Corning (Matrigel, 3D cell culture portfolio) and 3D Systems (Allevi).

Does Copner Biotech have an API?

No public API is recorded for Copner Biotech.

What industry is Copner Biotech in?

Copner Biotech's product category is Biofabrication Equipment. Its primary akta.pro industry code is IMAAAAAG, Bioprinting & Biofabrication Systems (Tissue/Cell Printing Hardware). Its NAICS code is 325211 and its SIC code is 2820.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales